← All Insights · Policy Sep 18, 2026 · 7 min read CIN Terminal · Synthesized from live signals · Sep 18, 2026 07:05 UTC HoldCIN Rating 58/100How is this calculated? TLRY and the Rescheduling Test: Cash Before Catalysts DEA process timing remains uncertain. For cannabis equities, Tilray’s fiscal 2027 cash-conversion test is a more durable policy read-through than headline volatility. Key takeaways Share X LinkedIn Email Copy link Found this useful? Share it X LinkedIn More like this, straight to your inbox One new CIN Insight + the week's top three signals from the live terminal. Free, weekly. Subscribe Related Insights